TuisE2Z • FRA
add
Almirall SA
Vorige sluiting
€8,29
Dagwisseling
€8,45 - €8,45
Jaarwisseling
€7,79 - €9,96
Markkapitalisasie
1,85 mjd EUR
Gemiddelde volume
22,00
P/V-verhouding
-
Dividend-opbrengs
2,18%
Primêre beurs
BME
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 231,12 m | 10,44% |
Bedryfskoste | 90,74 m | 7,23% |
Netto inkomste | -8,19 m | -616,72% |
Netto winsgrens | -3,54 | -565,79% |
Wins per aandeel | — | — |
EBITDA | 45,19 m | -11,73% |
Effektiewe belastingkoers | -389,83% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 343,10 m | 37,29% |
Totale bates | 2,31 mjd | -1,92% |
Totale aanspreeklikheid | 839,20 m | 2,30% |
Totale ekwiteit | 1,47 mjd | — |
Uitstaande aandele | 213,47 m | — |
Prys om te bespreek | 1,21 | — |
Opbrengs op bates | 0,23% | — |
Opbrengs op kapitaal | 0,29% | — |
Kontantvloei
Netto kontantverandering
| (EUR) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -8,19 m | -616,72% |
Kontant van bedrywe | 39,79 m | 667,72% |
Kontant van beleggings | 34,32 m | 165,79% |
Kontant van finansiering | -10,36 m | -29,76% |
Netto kontantverandering | 63,75 m | 194,91% |
Beskikbare kontantvloei | 125,43 m | 222,79% |
Meer oor
Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944.
In 2023, the company generated total revenues of €898.8 million and was the leading European company in medical dermatology.
With approximately 1,904 employees, it has a direct presence in 20 countries through its 15 subsidiaries in Europe and the USA. Wikipedia
Gestig
1944
Webwerf
Werknemers
1 996
